| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.43 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.44 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.36 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |